Altered expression of isoniazid-regulated genes in drug-treated dormant Mycobacterium tuberculosis.
about
Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungsA novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogenInterpreting expression data with metabolic flux models: predicting Mycobacterium tuberculosis mycolic acid productionSelf-poisoning of Mycobacterium tuberculosis by targeting GlgE in an alpha-glucan pathwayComparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig.Latent tuberculosis infection: myths, models, and molecular mechanismssenX3-independent contribution of regX3 to Mycobacterium tuberculosis virulenceEffectiveness of tuberculosis chemotherapy correlates with resistance to Mycobacterium tuberculosis infection in animal modelsComprehensive insights into transcriptional adaptation of intracellular mycobacteria by microbe-enriched dual RNA sequencingT cell monitoring of chemotherapy in experimental rat tuberculosis.Mycobacterium tuberculosis metabolismModels of latent tuberculosis: their salient features, limitations, and development.Genetic Approaches to Facilitate Antibacterial Drug Development.Depletion of M. tuberculosis GlmU from Infected Murine Lungs Effects the Clearance of the Pathogen.Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy.Transcriptional Adaptation of Drug-tolerant Mycobacterium tuberculosis During Treatment of Human TuberculosisRifapentine is not more active than rifampin against chronic tuberculosis in guinea pigsMycobacterium tuberculosis WhiB4 regulates oxidative stress response to modulate survival and dissemination in vivo.Upregulation of the phthiocerol dimycocerosate biosynthetic pathway by rifampin-resistant, rpoB mutant Mycobacterium tuberculosisCapillary electrophoresis-single strand conformation polymorphism for the detection of multiple mutations leading to tuberculosis drug resistanceConstruction and application of a co-expression network in Mycobacterium tuberculosis.Antitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitor.Potent rifamycin-sparing regimen cures guinea pig tuberculosis as rapidly as the standard regimenMetronidazole lacks activity against Mycobacterium tuberculosis in an in vivo hypoxic granuloma model of latencyMycobacterial disease in patients with rheumatic disease.Stringent Response Factors PPX1 and PPK2 Play an Important Role in Mycobacterium tuberculosis Metabolism, Biofilm Formation, and Sensitivity to Isoniazid In Vivo.DNA repair systems and the pathogenesis of Mycobacterium tuberculosis: varying activities at different stages of infection.Systems biology approaches to understanding mycobacterial survival mechanisms.In vitro and in vivo fitness costs associated with Mycobacterium tuberculosis RpoB mutation H526D.Adaptation of Mycobacterium tuberculosis to Impaired Host Immunity in HIV-Infected Patients.Sputum is a surrogate for bronchoalveolar lavage for monitoring Mycobacterium tuberculosis transcriptional profiles in TB patientsExamining the basis of isoniazid tolerance in nonreplicating Mycobacterium tuberculosis using transcriptional profiling.Differential regulation of the two-component regulatory system senX3-regX3 in Mycobacterium tuberculosis.Systems level mapping of metabolic complexity in Mycobacterium tuberculosis to identify high-value drug targets.Integration of heterogeneous molecular networks to unravel gene-regulation in Mycobacterium tuberculosis.
P2860
Q21089606-D8F751FD-6D50-4DF8-ABD2-96A961780C53Q28475648-EC72068B-14C3-4001-AED2-9C318873FB1FQ28475985-95CA824B-3C0D-4BA5-850B-A71779D2CF52Q28486696-95A98D39-E3E7-48E6-A895-142AD6459C44Q33723589-13BD52B1-D868-4C5C-98CF-2083E1B03F48Q34297816-3C12A310-2892-47EE-9AE2-BF60567AD20AQ34422808-FC5896BF-C4C2-4B8D-9617-A44F303A6AAEQ35037392-CB250AAE-A1EC-46CA-86ED-FC304F228413Q35102514-D8506916-41AF-4B51-BD88-EA7C79DAC0FBQ35139430-FF47813D-A992-46EB-87B5-C7312EB512FFQ35245286-1B3794D0-7264-4AA7-935A-565E36FF795FQ35646203-1E1B9B1D-F1F7-483C-B004-6A5884D59157Q35795582-DE319D88-2652-4E7A-A717-DE2890B7CEC8Q35816288-8C83464C-45FB-4B65-BF1D-08B3C8DD14C8Q35983023-25A86FA6-CBF2-452B-8A64-4818C2BE236CQ35993510-716D6E93-CD63-4567-AA45-859EA211150DQ36086369-370DE987-42F8-44AC-8C45-4D96442CB78BQ36223232-305B00E8-4943-4A75-9424-CCC4BBA2380DQ36397155-C93FAB3F-51FE-4A74-A87A-A3EFB74B7627Q36975566-6090BBE8-C768-4B61-8C3E-E36627EC6AA3Q37027580-686DD7F5-F936-4011-96D1-A1EDA61A9248Q37034701-D3764387-463D-4B01-A4A3-C4BB057B2322Q37036499-5A1C2CD4-09B9-4B8F-8317-BCEBCD85F840Q37109777-73D30EB3-9D61-4E22-908A-BBD791722A1BQ37335860-F174788E-69C2-423E-BA48-2BB2FEFAF60DQ37358614-7EF5D3DF-0CAD-447C-B7DF-4761E7ECED56Q37762580-0E603E03-D221-48FD-A26F-9AEDC44155CEQ37808939-101B8C23-AD81-4B1C-B1B2-E929509106CAQ38739681-7DE70C32-2339-49FD-ABA5-84D36101A862Q38853401-0EF025AD-6573-4EB1-83FB-D81354F931F9Q39017100-1C2CFAE2-B7F7-4419-B2A4-D3C8026E9C61Q39769328-8364E1FE-CD33-42DE-BDCB-D4CFBC985478Q40088108-02EE510F-A53C-437F-B519-7F56D6D0A83EQ42065966-E090AF80-9B30-4619-937A-21022570CE24Q42075255-4FB82B58-265A-4029-B187-55AB8AAB51F4
P2860
Altered expression of isoniazid-regulated genes in drug-treated dormant Mycobacterium tuberculosis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Altered expression of isoniazi ...... nt Mycobacterium tuberculosis.
@en
Altered expression of isoniazi ...... nt Mycobacterium tuberculosis.
@nl
type
label
Altered expression of isoniazi ...... nt Mycobacterium tuberculosis.
@en
Altered expression of isoniazi ...... nt Mycobacterium tuberculosis.
@nl
prefLabel
Altered expression of isoniazi ...... nt Mycobacterium tuberculosis.
@en
Altered expression of isoniazi ...... nt Mycobacterium tuberculosis.
@nl
P2093
P356
P1476
Altered expression of isoniazi ...... nt Mycobacterium tuberculosis.
@en
P2093
Ernest P Williams
Petros C Karakousis
William R Bishai
P304
P356
10.1093/JAC/DKM485
P407
P577
2007-12-21T00:00:00Z